Literature DB >> 32152797

Metabolomic abnormalities of purine and lipids implicated olfactory bulb dysfunction of CUMS depressive rats.

Yong He1,2, Yue Wang1,2,3, Zhonghao Wu1,2,4, Tianlan Lan1,2,4, Yu Tian1,2,5, Xi Chen1,2,6, Yan Li1,2,5, Ruozhi Dang1,2,5, Mengge Bai1,2,7, Ke Cheng8,9,10, Peng Xie11,12,13,14.   

Abstract

Major depressive disorder (MDD) is a serious mood disorder and leads to a high suicide rate as well as financial burden. The volume and function (the sensitivity and neurogenesis) of the olfactory bulb (OB) were reported to be altered among the MDD patients and rodent models of depression. In addition, the olfactory epithelium was newly reported to decrease its volume and function under chronic unpredictable mild stress (CUMS) treatment. However, the underlying molecular mechanism still remains unclear. Herein, we conducted the non-targeted metabolomics method based on gas chromatography-mass spectrometry (GC-MS) coupled with multivariate statistical analysis to characterize the differential metabolites in OB of CUMS rats. Our results showed that 19 metabolites were categorized into two perturbed pathways: purine metabolism and lipid metabolism, which were regarded as the vital pathways concerned with dysfunction of OB. These findings indicated that the turbulence of metabolic pathways may be partly responsible for the dysfunction of OB in MDD.

Entities:  

Keywords:  Chronic unpredictable mild stress; Major depressive disorder; Metabolomics; Olfactory bulb; Rats

Mesh:

Substances:

Year:  2020        PMID: 32152797     DOI: 10.1007/s11011-020-00557-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  5 in total

1.  Integration of Non-Targeted Metabolomics and Targeted Quantitative Analysis to Elucidate the Synergistic Antidepressant Effect of Bupleurum Chinense DC-Paeonia Lactiflora Pall Herb Pair by Regulating Purine Metabolism.

Authors:  Jiajun Chen; Tian Li; Xuemei Qin; Guanhua Du; Yuzhi Zhou
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

2.  Analysis of the therapeutic effect of Dimu Ningshen (TCM formula) on attention deficit hyperactivity disorder based on gut microbiota and serum metabolomics.

Authors:  Kairui Tang; Wenzhi Hao; Xiaowei Mo; Yueyue Chen; Xiaofang Guo; Liangliang He; Binghua Wang; Juxian Wang; Qingyu Ma; Lijuan Deng; Jiaxu Chen
Journal:  BMC Complement Med Ther       Date:  2022-01-25

3.  Metabolomics Based on Peripheral Blood Mononuclear Cells to Dissect the Mechanisms of Chaigui Granules for Treating Depression.

Authors:  Dehua Huang; Liwen Wang; Yanfei Wu; Xuemei Qin; Guanhua Du; Yuzhi Zhou
Journal:  ACS Omega       Date:  2022-03-07

4.  Abnormal prostate microbiota composition is associated with experimental autoimmune prostatitis complicated with depression in rats.

Authors:  Feng Liu; Xiaolin Xu; Zhong Wang; Peng Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-09-30       Impact factor: 6.073

5.  Chronic stress and antidepressant treatment alter purine metabolism and beta oxidation within mouse brain and serum.

Authors:  Peter J Hamilton; Emily Y Chen; Vladimir Tolstikov; Catherine J Peña; Joseph A Picone; Punit Shah; Kiki Panagopoulos; Ana N Strat; Deena M Walker; Zachary S Lorsch; Hannah L Robinson; Nicholas L Mervosh; Drew D Kiraly; Rangaprasad Sarangarajan; Niven R Narain; Michael A Kiebish; Eric J Nestler
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.